34. Lynn AK, Yannas IV, Bonfield W. Antigenicity and immunoge nicity of collagen. J Biomed Mater Res B Appl Biomater. 2004; 71(2): 343-54. https://doi.org/10.1002/jbm.b.30096.
35. Fujioka-Kobayashi M, Schaller B, Saulacic N, Zhang Y, Miron RJ. Growth factor delivery of BMP9 using a novel natural bovine bone graft with integrated atelo-collagen type I: Biosynthesis, characterization, and cell behavior. J Biomed Mater Res A. 2017; 105(2): 408-418. https://doi.org/10.1002/ jbm.a.35921.
36. Moon SH, Lee YJ, Rhie JW, Suh DS, Oh DY, Lee JH, Kim YJ, Kim SM, Jun YJ. Comparative study of the effectiveness and safety of porcine and bovine atelocollagen in Asian nasolabial fold correction. J Plast Surg Hand Surg. 2015; 49(3): 147-52. https://doi.org/10.3109/2000656X.2014.964725.
37. Veremeev AV, Kutikhin AG, Nesterenko VG, Bolgarin RN. Patent RU2665962C1. Bioresorbable bioscaffold for bone repair and the approach for its preparation. In Russ. (Патент РФ на изобретение № 2665962 «Биорезорбируемый биологический матрикс для замещения дефектов костной ткани и способ его получения»)
38. Spicer PP, Kretlow JD, Young S, Jansen JA, Kasper FK, Mikos AG. Evaluation of bone regeneration using the rat critical size calvarial defect. Nat Protoc. 2012; 7(10): 1918-29. https://doi. org/10.1038/nprot.2012.113.
39. Brydone AS, Meek D, Maclaine S. Bone grafting, orthopae dic biomaterials, and the clinical need for bone engineering . Proc Inst Mech Eng H. 2010; 224(12): 1329-43. https://doi. org/10.1243/09544119JEIM770.
40. O'Keefe RJ, Mao J. Bone tissue engineering and regenerat ion: from discovery to the clinic--an overview. Tissue Eng Part B Rev. 2011; 17(6): 389-92. https://doi.org/10.1089/ten. TEB.2011.0475.